[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA986475B - Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. - Google Patents

Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Info

Publication number
ZA986475B
ZA986475B ZA9806475A ZA986475A ZA986475B ZA 986475 B ZA986475 B ZA 986475B ZA 9806475 A ZA9806475 A ZA 9806475A ZA 986475 A ZA986475 A ZA 986475A ZA 986475 B ZA986475 B ZA 986475B
Authority
ZA
South Africa
Prior art keywords
carbazoly
propanole
loxy
methoxyphenoxy
ethylamino
Prior art date
Application number
ZA9806475A
Other languages
English (en)
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA986475B publication Critical patent/ZA986475B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA9806475A 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it. ZA986475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (de) 1997-07-22 1997-07-22 Eine thermodynamisch stabile Modifikation von 1-(4-Carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, Verfahren zu ihrer Herstellung und ihre enthaltende Arznemittel

Publications (1)

Publication Number Publication Date
ZA986475B true ZA986475B (en) 2000-01-21

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806475A ZA986475B (en) 1997-07-22 1998-07-21 Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.

Country Status (32)

Country Link
EP (2) EP0893440A1 (de)
JP (1) JP2001510824A (de)
KR (1) KR100336229B1 (de)
CN (1) CN1125047C (de)
AR (1) AR015133A1 (de)
AT (1) ATE236123T1 (de)
AU (1) AU740453B2 (de)
BR (1) BR9810776A (de)
CA (1) CA2296637C (de)
CZ (1) CZ296947B6 (de)
DE (1) DE69812964T2 (de)
DK (1) DK1000027T3 (de)
ES (1) ES2195366T3 (de)
HK (1) HK1029339A1 (de)
HR (1) HRP980406A2 (de)
HU (1) HUP0003198A3 (de)
IL (1) IL133677A (de)
MA (1) MA26523A1 (de)
MY (1) MY117734A (de)
NO (1) NO313588B1 (de)
NZ (1) NZ502136A (de)
PE (1) PE96999A1 (de)
PL (1) PL191602B1 (de)
PT (1) PT1000027E (de)
RU (1) RU2202542C2 (de)
SI (1) SI1000027T1 (de)
TR (1) TR200000148T2 (de)
TW (1) TW505631B (de)
UY (1) UY25108A1 (de)
WO (1) WO1999005105A1 (de)
YU (1) YU2200A (de)
ZA (1) ZA986475B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402336C (en) * 2000-04-03 2008-03-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (de) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Verfahren zur Herstellung einer kristallinen Form von Carvedilol (Form II)
IL153688A0 (en) 2000-06-28 2003-07-06 Teva Pharma Carvedilol
EP1406614B1 (de) * 2001-07-13 2006-06-07 Smithkline Beecham Corporation Carvedilolpolymorph
EP1929998A3 (de) 2001-09-21 2008-11-26 Egalet A/S Festdispersionen mit gesteuerter Freisetzung von Carvedilol
RU2308449C2 (ru) * 2001-09-28 2007-10-20 Ф.Хоффманн-Ля Рош Аг Псевдополиморфные формы карведилола
CN1298322C (zh) * 2002-01-15 2007-02-07 特瓦制药工业有限公司 卡维地洛的结晶固体及其制备方法
CA2483054A1 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
EP1539140A4 (de) 2002-06-27 2005-12-07 Sb Pharmco Inc Carvedilolhydobromid
BR0312102A (pt) 2002-06-27 2007-05-29 Sb Pharmco Inc sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (de) * 2003-11-25 2009-05-27 Sb Pharmco Inc Carvedilol-salze, entsprechende zusammensetzungen, verfahren zur abgabe und/oder behandlung
DK1838670T3 (da) * 2004-12-09 2010-03-01 Zach System Spa Fremgangsmåde til fremstilling af carvedilol og dets enantiomere
EP1781611A1 (de) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Kristalline formen des carvediols und verfahren zu ihrer herstellung
US8022094B2 (en) 2006-06-28 2011-09-20 Teva Pharmaceutical Industries Ltd. Carvedilol phosphate
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
YU2200A (sh) 2002-03-18
EP1000027B1 (de) 2003-04-02
NO313588B1 (no) 2002-10-28
ES2195366T3 (es) 2003-12-01
CA2296637C (en) 2005-11-15
ATE236123T1 (de) 2003-04-15
AR015133A1 (es) 2001-04-18
CZ2000221A3 (cs) 2000-05-17
MY117734A (en) 2004-07-31
PE96999A1 (es) 1999-10-12
BR9810776A (pt) 2000-09-19
CA2296637A1 (en) 1999-02-04
EP0893440A1 (de) 1999-01-27
HK1029339A1 (en) 2001-03-30
SI1000027T1 (en) 2003-10-31
HUP0003198A3 (en) 2002-10-28
DE69812964D1 (de) 2003-05-08
KR20010022097A (ko) 2001-03-15
MA26523A1 (fr) 2004-12-20
PT1000027E (pt) 2003-07-31
RU2202542C2 (ru) 2003-04-20
IL133677A (en) 2004-06-01
NO20000301L (no) 2000-01-21
NZ502136A (en) 2002-05-31
HRP980406A2 (en) 1999-04-30
JP2001510824A (ja) 2001-08-07
NO20000301D0 (no) 2000-01-21
TR200000148T2 (tr) 2000-07-21
PL338432A1 (en) 2000-11-06
CZ296947B6 (cs) 2006-08-16
AU8631998A (en) 1999-02-16
PL191602B1 (pl) 2006-06-30
DE69812964T2 (de) 2004-03-04
WO1999005105A1 (en) 1999-02-04
TW505631B (en) 2002-10-11
DK1000027T3 (da) 2003-07-21
KR100336229B1 (ko) 2002-05-09
EP1000027A1 (de) 2000-05-17
CN1264366A (zh) 2000-08-23
HUP0003198A2 (en) 2001-03-28
UY25108A1 (es) 2000-12-29
AU740453B2 (en) 2001-11-01
IL133677A0 (en) 2001-04-30
CN1125047C (zh) 2003-10-22

Similar Documents

Publication Publication Date Title
ZA986475B (en) Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
ZA988585B (en) Pharmaceutical compositions containing plasma protein.
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
HUP0200355A3 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0102372A2 (hu) Dihidropirimidin-származékok, ezek előállítása és ezeket tartalmazó gyógyszerkészítmények
ZA9710015B (en) Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications.
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
AU6120498A (en) 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
HK1029124A1 (en) Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them.
ZA984216B (en) Clear emulsion cosmetic compositions.
IL136937A0 (en) τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them